David Goldstein
Impact in
- Oncology top 0.05%
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
- Cancer survivorship and care
- Cancer Immunotherapy and Biomarkers
- Gastroenterology top 0.5%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 188
- Pancreatic and Hepatic Oncology Research 84
- Cancer Treatment and Pharmacology 53
- Cancer survivorship and care 22
- Colorectal Cancer Treatments and Studies 9
-
- Gastrointestinal Tumor Research and Treatment 18
- Co-authors
- Susanna B. Park (53 shared papers)Michael Leonard Friedlander (31 shared papers)Matthew C. Kiernan (29 shared papers)Phyllis Noemi Butow (46 shared papers)Arun V. Krishnan (21 shared papers)Minoti Vivek Apte (22 shared papers)Jeremy S. Wilson (21 shared papers)Romano C. Pirola (20 shared papers)
- Journals
- Annals of Oncology (25 papers)Supportive Care in Cancer (21 papers)Journal of Clinical Oncology (17 papers)British Journal of Cancer (12 papers)European Journal of Cancer (12 papers)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
David Goldstein
380 papers receiving 22.4k citations
David Goldstein's Hit Papers
Peers
Comparison fields: 5 of 139
- Oncology 11.1k
- Gastroenterology 605
- Cancer Research 475
- General Health Professions 626
- Pulmonary and Respiratory Medicine 957
Countries citing papers authored by David Goldstein
This map shows the geographic impact of David Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Goldstein more than expected).
Fields of papers citing papers by David Goldstein
This network shows the impact of papers produced by David Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Goldstein. The network helps show where David Goldstein may publish in the future.
Co-authors
The 25 scholars most cited alongside David Goldstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 391 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group Hit paper breakdown → | 2007 | 3124 |
| 2 | Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection Hit paper breakdown → | 2010 | 1106 |
| 3 | Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial Hit paper breakdown → | 2018 | 1060 |
| 4 | Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib Hit paper breakdown → | 2016 | 827 |
| 5 | Chemotherapy‐induced peripheral neurotoxicity: A critical analysis Hit paper breakdown → | 2013 | 614 |
| 6 | 2015 | 565 | |
| 7 | 2004 | 519 | |
| 8 | 2004 | 434 | |
| 9 | 2008 | 413 | |
| 10 | 2014 | 347 | |
| 11 | 2010 | 304 | |
| 12 | 2018 | 295 | |
| 13 | 2005 | 238 | |
| 14 | 2005 | 217 | |
| 15 | 2017 | 215 | |
| 16 | 2011 | 211 | |
| 17 | 2009 | 210 | |
| 18 | 2017 | 210 | |
| 19 | 2017 | 200 | |
| 20 | 2008 | 187 |
About David Goldstein
David Goldstein is a scholar working on Oncology, Gastroenterology, Pulmonary and Respiratory Medicine, General Health Professions and Otorhinolaryngology, having authored 391 papers that have together received 23.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (84 papers), Cancer Treatment and Pharmacology (53 papers), Cancer survivorship and care (22 papers), Gastrointestinal Tumor Research and Treatment (18 papers), Gastric Cancer Management and Outcomes (11 papers), Colorectal Cancer Treatments and Studies (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Head and Neck Cancer Studies (7 papers). The work is most often cited by research in Oncology (11.1k citations), Gastroenterology (605 citations), Cancer Research (475 citations), General Health Professions (626 citations) and Pulmonary and Respiratory Medicine (957 citations). David Goldstein has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Susanna B. Park, Michael Leonard Friedlander, Matthew C. Kiernan, Phyllis Noemi Butow, Arun V. Krishnan, Minoti Vivek Apte, Jeremy S. Wilson, Romano C. Pirola, Malcolm J. Moore and Cindy S.-Y. Lin. Their work appears in journals such as Annals of Oncology, Supportive Care in Cancer, Journal of Clinical Oncology, British Journal of Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.